Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0A3WQ
|
||||
| Drug Name |
Org-36764
|
||||
| Synonyms |
175890-65-0; ORG-38793; Org-36653; Org-36654; Org-36708; Org-36764
|
||||
| Indication | Unspecified | Investigative | [1] | ||
| Target and Pathway | |||||
| Target(s) | Antithrombin-III | Target Info | Modulator | ||
| KEGG Pathway | Complement and coagulation cascades | ||||
| PANTHER Pathway | Blood coagulation | ||||
| Pathway Interaction Database | Glypican 1 network | ||||
| Reactome | Intrinsic Pathway of Fibrin Clot Formation | ||||
| Common Pathway of Fibrin Clot Formation | |||||
| WikiPathways | Complement and Coagulation Cascades | ||||
| Formation of Fibrin Clot (Clotting Cascade) | |||||
| References | |||||
| REF 1 | Pre-clinical pharmacological profile of the novel glycoconjugate Org 36764 with both factor Xa and thrombin (IIa) inhibitory activities. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.